| 1F5L | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | AMR, SO4 BindingDB | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1OWD, 1U6Q | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design., Zeslawska E, Schweinitz A, Karcher A, Sondermann P, Sperl S, Sturzebecher J, Jacob U, J Mol Biol 2000 Aug 11;301(2):465-75. PMID:10926521 | ||||||||||||||
| Data retrieval |
![]() |
| View 1F5L in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |